Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 7/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4096630 | 0.90 | ALDH1A1 (0.50) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL181576 | 0.79 | ALDH1A1 (0.47) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL1851416 | 0.79 | ALDH1A1 (0.47) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL27943600 | 0.79 | ALDH1A1 (0.50) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL3026153 | 0.77 | THRB (0.40) | THRBALDH1A1TSHR | |
| SCHEMBL17868708 | 0.76 | ALDH1A1 (0.52) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| Acrylic Acid SCHEMBL31138121 | 0.75 | ALDH1A1 (0.43) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL29151971 | 0.75 | ALDH1A1 (0.46) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL17936300 | 0.74 | ALDH1A1 (0.50) | THRBALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL7934785 | 0.73 | TSHR (0.48) | THRBALDH1A1TP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10000657-B2 | Fluorine-containing urethane (meth)acrylate, curable composition, and antireflective film | DIC CORPORATION (JP) | 2018-06-19 | — | — | US | disclosed |
| US-9604918-B2 | Carboxylic acid ester/carbamate compound with polymerizable functional group and fluorine atom group, and manufacturing method therefor | UNIMATEC CO., LTD. (JP) | 2017-03-28 | — | — | US | disclosed |
| EP-3127897-A1 | CARBOXYLIC ESTER / CARBAMATE COMPOUND WITH POLYMERIZABLE FUNCTIONAL GROUP AND FLUORINE ATOM GROUP, AND MANUFACTURING METHOD THEREFOR | Unimatec Co., Ltd. (JP) | 2017-02-08 | — | — | EP | disclosed |
| US-20160208131-A1 | FLUORINE-CONTAINING URETHANE (METH)ACRYLATE, CURABLE COMPOSITION, AND ANTIREFLECTIVE FILM | DIC CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
| US-20160185714-A1 | CARBOXYLIC ACID ESTER/CARBAMATE COMPOUND WITH POLYMERIZABLE FUNCTIONAL GROUP AND FLUORINE ATOM GROUP, AND MANUFACTURING METHOD THEREFOR | UNIMATEC CO., LTD. (JP) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160185714-A1 | CARBOXYLIC ACID ESTER/CARBAMATE COMPOUND WITH POLYMERIZABLE FUNCTIONAL GROUP AND FLUORINE ATOM GROUP, AND MANUFACTURING METHOD THEREFOR | FFAR2, DECR2, FFAR1 | THRB 1091/4885ALDH1A1 557/4885TP53 1890/4885 |
| US-20160208131-A1 | FLUORINE-CONTAINING URETHANE (METH)ACRYLATE, CURABLE COMPOSITION, AND ANTIREFLECTIVE FILM | TET1, MGMT, AFF1 | THRB 1411/4885ALDH1A1 343/4885TP53 4201/4885 |
| US-10000657-B2 | Fluorine-containing urethane (meth)acrylate, curable composition, and antireflective film | TET1, MGMT, AFF1 | THRB 1411/4885ALDH1A1 343/4885TP53 4201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.